Literature DB >> 7927306

Gastrointestinal lymphoma.

P G Isaacson1.   

Abstract

Primary gastrointestinal lymphoma comprises a group of distinctive clinicopathological entities, most of which are not included in current lymph node-based lymphoma classifications. They may be of B- or T-cell type, with primary gastrointestinal Hodgkin's disease being extremely uncommon. Most low grade B-cell gastrointestinal lymphomas are of mucosa-associated lymphoid tissue (MALT) type, so called because they recapitulate the features of MALT rather than those of lymph nodes. Paradoxically, however, most MALT lymphomas arise in the stomach, which normally contains no organized lymphoid tissue. These gastric MALT lymphomas appear to arise in MALT acquired as a reaction to infection of the stomach by Helicobacter pylori and their growth can be influenced by eradication of this organism from the stomach. Low grade MALT lymphomas, which usually have a very favorable clinical course, may undergo high grade transformation; high grade tumours also may arise de novo and these probably also belong to the MALT group. Immunoproliferative small intestinal disease (IPSID) is a special form of MALT lymphoma with a restricted geographic distribution, which is characterized by synthesis of alpha heavy-chain immunoglobulin. Other gastrointestinal B-cell lymphomas include mantle cell lymphoma, which presents as lymphomatous polyposis, and Burkitt's or Burkitt-like lymphoma. Enteropathy (celiac disease)-associated T-cell lymphoma (EATL) is the most common primary gastrointestinal T-cell lymphoma. This is a clinically aggressive tumor that arises from the intraepithelial T-cell population, which is increased in celiac disease.

Entities:  

Mesh:

Year:  1994        PMID: 7927306     DOI: 10.1016/0046-8177(94)90060-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  54 in total

1.  Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.

Authors:  E Berti; D Tomasini; M H Vermeer; C J Meijer; E Alessi; R Willemze
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  Primary gastric T-cell lymphoma accompanied by HTLV-I, HBV and H. pylori infection.

Authors:  T Itatsu; H Miwa; R Ohkura; R Iwazaki; H Oide; T Murai; M Nakajima; S Watanabe; S Hirai; M Otaka; N Sato
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

3.  Clinicopathologic study of primary intestinal B cell malignant lymphoma.

Authors:  Qin Zhou; Tian-Rong Xu; Qin-He Fan; Zou-Xung Zhen
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

4.  Primary gastrointestinal follicular center lymphoma resembling multiple lymphomatous polyposis.

Authors:  Y Sakata; R Iwakiri; H Sakata; J Fujisaki; M Mizuguchi; N Fukushima; K Fujimoto
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

5.  Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation.

Authors:  A Greiner; C Knörr; Y Qin; W Sebald; A Schimpl; J Banchereau; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

6.  Receptor revision of immunoglobulin heavy chain genes in human MALT lymphomas.

Authors:  D Lenze; A Greiner; C Knörr; I Anagnostopoulos; H Stein; M Hummel
Journal:  Mol Pathol       Date:  2003-10

7.  Efficacy of rituximab in gastric diffuse large B cell lymphoma patients.

Authors:  Davide Leopardo; Giuseppe Di Lorenzo; Amalia De Renzo; Piera Federico; Serena Luponio; Carlo Buonerba; Elide Matano; Gerardina Merola; Martina Imbimbo; Enzo Montesarchio; Antonio Rea; Maria-Carmela Merola; Sabino De Placido; Giovannella Palmieri
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

8.  Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue.

Authors:  Antoine de Mascarel; Agnès Ruskone-Fourmestraux; Anne Lavergne-Slove; Francis Megraud; Pierre Dubus; Jean-Philippe Merlio
Journal:  Virchows Arch       Date:  2005-03-02       Impact factor: 4.064

9.  Pathology of deaths associated with "ecstasy" and "eve" misuse.

Authors:  C M Milroy; J C Clark; A R Forrest
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

10.  ¹⁸F-FDG PET/CT imaging for a gastrointestinal mantle cell lymphoma with multiple lymphomatous polyposis.

Authors:  Makoto Saito; Masaya Miyazaki; Mishie Tanino; Shinya Tanaka; Kencho Miyashita; Koh Izumiyama; Akio Mori; Tatsuro Irie; Masanori Tanaka; Masanobu Morioka; Eriko Tsukamoto
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.